{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T05:28:42Z","timestamp":1738042122666,"version":"3.33.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.htct.2023.12.002","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T21:14:29Z","timestamp":1706649269000},"page":"S405-S409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S6","title":["Cytogenetic findings in testicular relapse of multiple myeloma: case report and literature review"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2107-6174","authenticated-orcid":false,"given":"Mar\u00edlia Bazzo","family":"Catto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta Maria da Silva Oliveira","family":"Safranauskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0718-2391","authenticated-orcid":false,"given":"Tarcila Santos","family":"Datoguia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Kiyomi","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Borri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8610-6716","authenticated-orcid":false,"given":"Maria Gabriella","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Carolinne Leal do","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5140-5310","authenticated-orcid":false,"given":"Nelson","family":"Hamerschlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira Deolinda Rodrigues Pereira","family":"Velloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2023.12.002_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00527-y","article-title":"Extramedullary disease in multiple myeloma","volume":"11","author":"Bansal","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.htct.2023.12.002_bib0002","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1200\/JCO.2011.34.9290","article-title":"Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach","volume":"29","author":"Blad\u00e9","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.htct.2023.12.002_bib0003","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/annonc\/mdp329","article-title":"Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients","volume":"21","author":"Varettoni","year":"2010","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.htct.2023.12.002_bib0004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ajh.10174","article-title":"Testicular plasmacytoma: report of a case and review of the literature","volume":"71","author":"Anghel","year":"2002","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.htct.2023.12.002_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00277-019-03895-5","article-title":"Clonal evolution of one rare case of multiple myeloma with bilateral testicular mass as initial presentation","volume":"99","author":"Lin","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.htct.2023.12.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106403","article-title":"Disturbed MAPK pathway in early bilateral testicular extramedullary relapse of multiple myeloma","volume":"95","author":"Huang","year":"2020","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.htct.2023.12.002_bib0007","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1097\/RLU.0000000000004496","article-title":"Unusual extramedullary manifestation in multiple myeloma","volume":"48","author":"Strauss","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.htct.2023.12.002_bib0008","article-title":"Bilateral synchronous testicular involvement in multiple myeloma","volume":"83","author":"Castagna1","year":"1997","journal-title":"Case Report Rev Literature"},{"issue":"10","key":"10.1016\/j.htct.2023.12.002_bib0009","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0210-4806(08)73986-X","article-title":"Plasmocitoma testicular bilateral secundario. Aportaci\u00f3n de un caso y revisi\u00f3n de la literatura","volume":"32","author":"Garrido Abad","year":"2008","journal-title":"Actas Urol Esp"},{"issue":"3 Part 1","key":"10.1016\/j.htct.2023.12.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5347(05)67307-7","article-title":"Bilateral synchronous testicular plasmacytoma","volume":"164","author":"Pham","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.htct.2023.12.002_bib0011","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/bjh.17338","article-title":"Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations","volume":"194","author":"Rosi\u00f1ol","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.htct.2023.12.002_bib0012","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bjhh.2016.01.005","article-title":"Validation of interphase fluorescence in situ hybridization (iFISH) for multiple myeloma using CD138 positive cells","volume":"38","author":"Kishimoto","year":"2016","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"1","key":"10.1016\/j.htct.2023.12.002_bib0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00277-016-2847-z","article-title":"The possible role of burden of therapy on the risk of myeloma extramedullary spread","volume":"96","author":"Mangiacavalli","year":"2017","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.htct.2023.12.002_bib0014","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3324\/haematol.2012.065698","article-title":"Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents","volume":"97","author":"Usmani","year":"2012","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.htct.2023.12.002_bib0015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/bjh.13382","article-title":"Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations","volume":"169","author":"Varga","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.htct.2023.12.002_bib0016","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0037-1963(01)90021-6","article-title":"Targeted therapy for multiple myeloma","volume":"38","author":"Anderson","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.htct.2023.12.002_bib0017","unstructured":"Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chains."},{"issue":"2","key":"10.1016\/j.htct.2023.12.002_bib0018","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2141.2002.03258.x","article-title":"Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma","volume":"116","author":"Dahl","year":"2002","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.htct.2023.12.002_bib0019","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.leukres.2013.06.020","article-title":"T(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome","volume":"37","author":"An","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.htct.2023.12.002_bib0020","first-page":"175","article-title":"Multiple myeloma: evolving genetic events and host interactions","volume":"2","author":"Kuehl","year":"2002"},{"issue":"1","key":"10.1016\/j.htct.2023.12.002_bib0021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bjh.12223","article-title":"Cytogenetics of extramedullary manifestations in multiple myeloma","volume":"161","author":"Billecke","year":"2013","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.htct.2023.12.002_bib0022","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ejh.12688","article-title":"Cytogenetics in multiple myeloma patients progressing into extramedullary disease","volume":"97","author":"Besse","year":"2016","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.htct.2023.12.002_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/787809","article-title":"Extramedullary manifestation in multiple myeloma bears high incidence of poor cytogenetic aberration and novel agents resistance","author":"Qu","year":"2015","journal-title":"Biomed Res Int"},{"issue":"7","key":"10.1016\/j.htct.2023.12.002_bib0024","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00277-012-1414-5","article-title":"Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases","volume":"91","author":"Rasche","year":"2012","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.htct.2023.12.002_bib0025","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clml.2014.12.013","article-title":"Features of extramedullary disease of multiple myeloma: high frequency of P53 deletion and poor survival: a retrospective single-center study of 834 cases","volume":"15","author":"Deng","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"10.1016\/j.htct.2023.12.002_bib0026","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3324\/haematol.12005","article-title":"Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics","volume":"93","author":"Bink","year":"2008","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.htct.2023.12.002_bib0027","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.clml.2014.12.007","article-title":"The t(11;14)(q13;q32) translocation as a poor prognostic parameter for autologous stem cell transplantation in myeloma patients with extramedullary plasmacytoma","volume":"15","author":"Shin","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"10.1016\/j.htct.2023.12.002_bib0028","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bbmt.2009.11.025","article-title":"Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy","volume":"16","author":"Nemec","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.htct.2023.12.002_bib0029","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/10428194.2014.924116","article-title":"Chromosome 8q24.1\/c-MYC abnormality: a marker for high-risk myeloma","volume":"56","author":"Glitza","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.htct.2023.12.002_bib0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood-2004-03-0833","article-title":"Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors","volume":"105","author":"Rasmussen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.htct.2023.12.002_bib0031","series-title":"Blood Reviews","first-page":"56","article-title":"The impact of NF-\u03baB signaling on pathogenesis and current treatment strategies in multiple myeloma","author":"Vr\u00e1bel","year":"2019"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924000063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924000063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:06:33Z","timestamp":1737975993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137924000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":31,"alternative-id":["S2531137924000063"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2023.12.002","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetic findings in testicular relapse of multiple myeloma: case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2023.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}